The initial public offering (IPO) for Modern Diagnostic Research Centre, a pathology and radiology services chain, concluded its three-day subscription period on January 2, 2026. The IPO, an entirely fresh issue of 4.1 million equity shares, garnered significant investor interest, being oversubscribed approximately 28.77 times. Strong demand was observed across non-institutional investors (NIIs) and retail categories, with QIBs also oversubscribing their portion. Grey market premiums indicated a positive sentiment, with shares trading at a 15.56% premium.